JPS6143038B2 - - Google Patents
Info
- Publication number
- JPS6143038B2 JPS6143038B2 JP17092879A JP17092879A JPS6143038B2 JP S6143038 B2 JPS6143038 B2 JP S6143038B2 JP 17092879 A JP17092879 A JP 17092879A JP 17092879 A JP17092879 A JP 17092879A JP S6143038 B2 JPS6143038 B2 JP S6143038B2
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- isocitrate lyase
- strain
- medium
- brevibacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 28
- 229960002989 glutamic acid Drugs 0.000 claims description 15
- 108020003285 Isocitrate lyase Proteins 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 241000186146 Brevibacterium Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- HMVYERAUBSAVAX-UHFFFAOYSA-N 1-nitro-1-nitrosoguanidine Chemical compound NC(=N)N(N=O)[N+]([O-])=O HMVYERAUBSAVAX-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
この発明は発酵法によるL−グルタミン酸の製
造法に関する。
L−グルタミン酸は、ブレビバクテリウム属又
はコリネバクテリウム属に属する微生物を使用し
て発酵法により製造されている。
本発明者らは、従来知られているブレブバクテ
リウム属のL−グルタミン酸生産菌より、イソク
エン酸リアーゼ(4・1・3・1Ls−isocitrate
glyoxalate−lyase)が低下した変異株を誘導した
ところ、この変異株が従来知られているL−グル
タミン酸生産菌より高い収率でL−グルタミン酸
を生成蓄積することを知つた。
本発明に使用する変異株は、ブレビバクテリウ
ム属に属し、イソクエン酸リアーゼが低下した変
異株である。具体的に例示すれば以下の変異株が
ある。
ブレビバクテリウム・ラクトフエルメンタム
AJ 11516 FERM−P 5336
(酢酸要求性、イソクエン酸リアーゼ低下株)
ブレビバクテリウム・フラバム
AJ 11518 FERM−P 5338
(イソクエン酸リアーゼ低下株)
AJ 11516はATCC 13869を、AJ 11518は
ATCC 14067を、それぞれ親株として誘導され
た。他に親株としては、ブレビバクテリウム・サ
ツカロリテイカムATCC14066、ブレビバクテリ
ウム・デイバリカタム ATCC14020等のブレビ
バクテリウム属のL−グルタミン酸生産菌が使用
できる。
本発明でいう「イソクエン酸リアーゼ低下と
は」イソクエン酸リアーゼ活性が検出されない迄
に低下した、イソクエン酸リアーゼ欠失株も当然
含まれる。
上記変異株の変異誘導方法としては、紫外線照
射、放射線照射、変異誘導起剤処理等の通常の方
法が用いられ、例えば、200μg/mlのN−メチル
−N1−ニトロ−N−ニトロソグアニジンで0℃
で20分間処理する方法等がある。
これらの変異株のイソクエン酸リアーゼ活性を
親株と比較して測定した結果を第1表に示す。
This invention relates to a method for producing L-glutamic acid by fermentation. L-glutamic acid is produced by a fermentation method using microorganisms belonging to the genus Brevibacterium or Corynebacterium. The present inventors developed isocitrate lyase (4.1.3.1Ls-isocitrate lyase) from a conventionally known L-glutamic acid producing bacterium of the genus Brevobacterium.
They induced a mutant strain with reduced levels of L-glutamic acid (glyoxalate-lyase) and found that this mutant strain produced and accumulated L-glutamic acid at a higher yield than previously known L-glutamic acid producing bacteria. The mutant strain used in the present invention belongs to the genus Brevibacterium and is a mutant strain with reduced isocitrate lyase. Specific examples include the following mutant strains. Brevibacterium lactofermentum AJ 11516 FERM-P 5336 (acetic acid auxotrophy, isocitrate lyase reduced strain) Brevibacterium flavum AJ 11518 FERM-P 5338 (isocitrate lyase reduced strain) AJ 11516 is ATCC 13869, AJ 11518 is
ATCC 14067 was derived as the parent strain, respectively. Other parent strains that can be used include L-glutamic acid producing bacteria of the genus Brevibacterium, such as Brevibacterium satucaroliticum ATCC14066 and Brevibacterium devaricatam ATCC14020. "Reduced isocitrate lyase" as used in the present invention naturally includes an isocitrate lyase-deficient strain in which the isocitrate lyase activity has decreased to the point where it is undetectable. As methods for inducing mutations in the above mutant strains, conventional methods such as ultraviolet irradiation, radiation irradiation, and treatment with mutagenic agents are used. For example, 200 μg/ml N-methyl-N 1 -nitro-N-nitrosoguanidine 0℃
There are methods such as processing for 20 minutes. Table 1 shows the results of measuring the isocitrate lyase activity of these mutant strains in comparison with the parent strain.
【表】
イソクエン酸リアーゼ活性は次の様にして検定
した。
グルコース2.5g/dl、酢酸アンモニウム0.8g/
dl、KH2PO40.1g/dl、MgSO4・7H2O0.1g/dl、
FeSO4・7H2O1mg/dl、MnSO4・4H2O1mg/dl、尿
素0.4g/dl、ビオチン0.3μg/dl、サイアミン塩
酸塩20μg/dl及び大豆分解濃縮液(T−Nとし
て)48mg/dl(PH7.0)を含有する培地を調整し、
その20mlずつを500ml容振盪フラスコに入れ115℃
で10分間加熱殺菌した。この培地に試験菌株を接
種し、往復振盪培養機により31.5℃で、対数増殖
初期(10〜16時間)まで培養した。培養液より菌
体を分離し、洗浄後超音波破砕し、セフアデツク
スG−10で処理したものを酵素標品として用い
た。
酵株活性の測定は、椎尾らの方法に準じて行な
つた。
(ジヤーナル・オブ・バイオケミストリー 49
巻、262頁、1961年)
これらの菌株を用いてL−グルタミン酸を生成
蓄積せしめる方法は、従来のL−グルタミン酸生
成微生物の培養に採用されていた方法が用いられ
る。即ち炭素源としては、例えば甘蔗、甜菜から
の糖汁あるいは廃糖蜜、澱粉質原料加水分解物等
の糖質原料、酢酸、エチルアルコール等が用いら
れる。
窒素源としては例えば通常のL−グルタミン酸
発酵に用いられるアンモニウム塩、アンモニア
水、アンモニアガス、尿素等が用いられ、その他
必要に応じて、りん酸塩、マグネシウム塩等の無
機イオンが適宜培地に添加される。また必要に応
じてサイアミン、ビオチン等の微量栄養素が適宜
使用される。さらに、ビオチンが過剰に存在する
培地には、ポリオキシエチレンソルビタンモノパ
ルミテート、ペニシリン等のビオチン作用抑制物
質が常法により培地に添加される。培養は好気的
条件下で行うのがよく、培養温度は24〜37℃、培
養中PHは6〜9に制御するのがよく、PHの調整に
は無機あるいは有機の酸性あるいはアルカリ性物
質、さらには尿素、炭酸カルシウム、アルモニア
ガス等を使用することができる。発酵液からのL
−グルタミン酸の採取はイオン交換樹脂法、その
他の公知の方法を適宜組合せることにより行われ
る。
実施例 1
グルコーズ2.3g/dl、酢酸アンモニウム1g/
dl、酢酸ナトリウム1g/dl、KH2PO40.1g/dl、
MgSO4・7H2O0.1g/dl、サイアミン塩酸塩20μ
g/dl、尿素0.6g/dl、FeSO4・7H2O1mg/dl、
MnSO4・4H2O1mg/dl、大豆分解濃縮液(T−N
として)36mg/dlおよびビオチン2μg/(PH
7.0)を含有する培地を調製し、その20mlずつを
500ml容振盪フラスコに入れ115℃で10分加熱殺菌
した。この培地にそれぞれ下記の表の菌を接種し
往復振盪培養器により31.5℃で培養を行つた。
なお、培養中は培養液をPH6.5〜8.0に保つた
め、45g/dl尿素又は、2N H2SO4を用いて調製
した。
36時間で、培養を終了し、培養液中に蓄積した
L−グルタミン酸の対基質収率を求めた。その結
果を、次の第2表に示す。[Table] Isocitrate lyase activity was assayed as follows. Glucose 2.5g/dl, ammonium acetate 0.8g/dl
dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O0.1g/dl,
FeSO 4・7H 2 O1mg/dl, MnSO 4・4H 2 O1mg/dl, urea 0.4g/dl, biotin 0.3μg/dl, thiamine hydrochloride 20μg/dl and soybean decomposition concentrate (as T-N) 48mg/dl Adjust the medium containing (PH7.0),
Pour 20ml of each into a 500ml shaking flask and heat to 115°C.
sterilized by heating for 10 minutes. The test strain was inoculated into this medium and cultured at 31.5°C in a reciprocating shaking incubator until the early stage of logarithmic growth (10 to 16 hours). Bacterial cells were separated from the culture solution, washed, disrupted by ultrasonication, and treated with Sephadex G-10, and used as an enzyme preparation. The yeast strain activity was measured according to the method of Shiio et al. (Journal of Biochemistry 49
vol., p. 262, 1961) The method for producing and accumulating L-glutamic acid using these strains is the same as the conventional method used for culturing L-glutamic acid-producing microorganisms. That is, as the carbon source, for example, sugar juice or blackstrap molasses from sugar beet or sugar beet, carbohydrate raw materials such as starchy raw material hydrolysates, acetic acid, ethyl alcohol, etc. are used. As nitrogen sources, for example, ammonium salts, aqueous ammonia, ammonia gas, urea, etc. used in normal L-glutamic acid fermentation are used, and inorganic ions such as phosphates and magnesium salts are added to the medium as necessary. be done. Additionally, micronutrients such as thiamine and biotin are used as appropriate. Furthermore, a biotin action inhibitor such as polyoxyethylene sorbitan monopalmitate or penicillin is added to the medium in which biotin is present in excess by a conventional method. Cultivation is preferably carried out under aerobic conditions, with a culture temperature of 24 to 37°C and a pH of 6 to 9 during cultivation. To adjust the pH, use inorganic or organic acidic or alkaline substances, and Urea, calcium carbonate, alumonia gas, etc. can be used. L from fermentation liquid
- Glutamic acid is collected by appropriately combining the ion exchange resin method and other known methods. Example 1 Glucose 2.3g/dl, ammonium acetate 1g/dl
dl, sodium acetate 1g/dl, KH 2 PO 4 0.1g/dl,
MgSO 4・7H 2 O0.1g/dl, thiamine hydrochloride 20μ
g/dl, urea 0.6g/dl, FeSO 4・7H 2 O1mg/dl,
MnSO 4・4H 2 O1mg/dl, soybean decomposition concentrate (T-N
) 36 mg/dl and biotin 2 μg/(PH
Prepare a medium containing 7.0) and add 20 ml of it to each
The mixture was placed in a 500 ml shaking flask and sterilized by heating at 115°C for 10 minutes. Each of the bacteria shown in the table below was inoculated into this medium and cultured at 31.5°C in a reciprocating shaking incubator. During cultivation, 45 g/dl urea or 2N H 2 SO 4 was used to maintain the pH of the culture solution at 6.5 to 8.0. After 36 hours, the culture was terminated, and the substrate yield of L-glutamic acid accumulated in the culture solution was determined. The results are shown in Table 2 below.
【表】
実施例 2
グルコース10g/dl、KH2PO40.1g/dl、
MgSO4・7H2O0.1g/dl、サイアミン塩酸塩20μ
g/dl、大豆分解濃縮液(T−Nとして)36mg/
dl、硫安2.0g/dl、FeSO4・7H2O1mg/dl
MnSO4・4H2O1mg/dlおよびビチン3μg/dl、
(PH7.0)を含有する培地を調整し、その20mlずつ
を500ml容振盪フラスコに入れ115℃で10分間加熱
殺菌した。この培地にそれぞれ下記の表の菌を接
種し往復振盪培養液により31.5℃で培養を行つ
た。
なお、培養中は培養液をPH6.5〜8.0に保つた
め、5g/dlの炭酸カルシウムを添加した。また
24時間目に2.5g/dlの硫安を添加し、46時間で発
酵を終了し、発酵液中に蓄積したL−グルタミン
酸の対糖収率を求めた。その結果を次の第3表に
示す。[Table] Example 2 Glucose 10g/dl, KH 2 PO 4 0.1g/dl,
MgSO 4・7H 2 O0.1g/dl, thiamine hydrochloride 20μ
g/dl, soybean decomposition concentrate (as T-N) 36mg/
dl, ammonium sulfate 2.0g/dl, FeSO 4・7H 2 O1mg/dl
MnSO 4 4H 2 O 1 mg/dl and bitin 3 μg/dl,
(PH7.0) was prepared, and 20 ml of each was placed in a 500 ml shaking flask and sterilized by heating at 115°C for 10 minutes. Each of the bacteria shown in the table below was inoculated into this medium and cultured at 31.5°C using a reciprocating shaking culture solution. During cultivation, 5 g/dl of calcium carbonate was added to maintain the pH of the culture solution at 6.5 to 8.0. Also
At 24 hours, 2.5 g/dl of ammonium sulfate was added, the fermentation was completed in 46 hours, and the yield of L-glutamic acid accumulated in the fermentation liquid relative to sugar was determined. The results are shown in Table 3 below.
Claims (1)
リアーゼ(4・1・3・1 Ls−isocitrate
glyoxalatelyase)が低下した変異株を培養し、培
地中に生成蓄積されたL−グルタミン酸を採取す
ることを特徴とする発酵法によるL−グルタミン
酸の製造法。1 Belongs to the genus Brevibacterium and produces isocitrate lyase (4.1.3.1 Ls-isocitrate
1. A method for producing L-glutamic acid by a fermentation method, which comprises culturing a mutant strain with reduced levels of glyoxalatelyase and collecting L-glutamic acid produced and accumulated in a medium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17092879A JPS5692795A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17092879A JPS5692795A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5692795A JPS5692795A (en) | 1981-07-27 |
| JPS6143038B2 true JPS6143038B2 (en) | 1986-09-25 |
Family
ID=15913952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17092879A Granted JPS5692795A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5692795A (en) |
-
1979
- 1979-12-27 JP JP17092879A patent/JPS5692795A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5692795A (en) | 1981-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4529697A (en) | Process for producing L-glutamic acid by fermentation | |
| JPS6236676B2 (en) | ||
| JP3301140B2 (en) | Method for producing L-glutamic acid by fermentation method | |
| JPS6321479B2 (en) | ||
| JP3008565B2 (en) | Method for producing L-glutamic acid by fermentation method | |
| JPS6115695A (en) | Preparation of l-isoleucine by fermentation method | |
| US4389483A (en) | Method for producing L-glutamic acid by fermentation | |
| US4368266A (en) | Method for producing L-glutamic acid by fermentation | |
| JPS6143038B2 (en) | ||
| JPS6257316B2 (en) | ||
| US5019503A (en) | Method for production of l-threonine | |
| JPS6236677B2 (en) | ||
| KR960009066B1 (en) | Fermentation method for preparing L-glutamic acid | |
| JPH0594A (en) | Method for producing anthranilic acid by fermentation | |
| KR900000938B1 (en) | Method for preparing L-glutamic acid by fermentation | |
| KR890003710B1 (en) | Method for preparing L-glutamic acid by fermentation | |
| JPS6224075B2 (en) | ||
| JP2995816B2 (en) | Production method of L-lysine by fermentation method | |
| JPH0129555B2 (en) | ||
| JP2817228B2 (en) | Method for producing L-glutamic acid | |
| JPS6236675B2 (en) | ||
| JPH04166092A (en) | Production of l-lysine by fermentation | |
| JPH0354550B2 (en) | ||
| JPH0561914B2 (en) | ||
| JPH0358716B2 (en) |